Seven months ago the federal government told Americans to eat roughly twice as much protein. On January 7, HHS and USDA released the 2025–2030 Dietary Guidelines for Americans with a target of 1.2 to 1.6 grams per kilogram of body weight per day — about 0.5 to 0.7 grams per pound. The number it replaced, 0.8 grams per kilogram, had been the reference intake for more than seven decades. Grocery shelves had already run ahead of the guidance: protein cereal, protein coffee, protein water.
On Thursday, the other shoe. Bailey Knopf and Dudley Lamming of the University of Wisconsin–Madison published a review in the Cell Press journal Cell Press Blue covering more than 350 papers on protein restriction and aging. Their conclusion runs the opposite direction: eating less protein appears to improve metabolism, alter how cells respond to nutrients, reduce cellular damage and preserve healthy cell function — and in animals, extend lifespan.
“It’s absolutely crystal clear that there are benefits of protein to muscle growth and exercise response of active individuals,” Lamming, the paper’s corresponding author, said. “But because most people are relatively sedentary, many people are likely consuming more protein than they actually need, which probably has negative health consequences.”
What the review actually assembles
Not new experiments — a map of mechanisms that keep recurring across decades of work. Flies and rodents have lived longer on lower-protein diets without cutting calories at all. Several recent human trials found that lowering protein reduced weight and fat mass and improved fasting blood sugar, even though the protein-restricted participants tended to eat more total calories.
The recurring lever is a hormone: fibroblast growth factor 21, or FGF21, which rises when protein intake drops. It raises energy expenditure, improves blood sugar control and reduces inflammation. Mice with elevated FGF21 outlived normal mice, more strongly in males than females. Human protein restriction raises FGF21 too.
The review also narrows the culprit from “protein” to three amino acids — methionine, isoleucine and valine. Too much of these appears to switch on growth pathways, and growth pathways left permanently on are associated with obesity, inflammation and age-related disease. That is a different claim from “eat less protein.” It is closer to “composition matters as much as total.”
Our take: This is a review, and most of the lifespan evidence underneath it is animal evidence. Nobody has run the trial where humans eat less protein for thirty years and someone counts the funerals. But the two sides are not really contradicting each other — they are answering different questions for different people. The guidelines were written to solve muscle loss in aging and satiety in weight management, both real. The review describes what happens to metabolism in a body that isn’t training. The single number in the middle is doing work it cannot do. Athletes eat enormous amounts of protein without developing metabolic disease; Lamming’s suspicion is that exercise protects them by routing protein into muscle instead of into signaling. If that’s right, the dose is meaningless without the activity level attached — and activity level is the part almost nobody reports honestly.
The variable neither document prices in
Lamming makes the point directly: “Recent recommendations have encouraged people to eat more protein, but they’ve also encouraged people to exercise more. We probably need to personalize protein recommendations based not just on age, but also on how physically active people are.”
That splits the population in a way a label cannot. Pregnant women and some older adults genuinely need more. People who train hard have a use for it. For the large sedentary middle — the exact demographic the fortified aisle is priced for — the review’s argument is that fortification is buying something other than what the shopper thinks.
Which is why this will not stay in a journal. A federal guideline that nearly doubles a macronutrient target is a demand signal: it reformulates products, rewrites institutional menus, moves marketing budgets. Walking that back is expensive in a way walking it forward never was.
What to watch
- Whether the guidance gets an activity qualifier. The cheapest fix isn’t changing the number, it’s attaching a condition to it. Watch for professional bodies issuing activity-stratified guidance ahead of the federal cycle.
- Amino acid composition. If methionine, isoleucine and valine hold up as the active variables, the question becomes protein source, not grams — and plant-versus-animal stops being ideological and becomes technical.
- FGF21 as a drug target. A hormone that raises energy expenditure and improves glucose control without requiring dietary compliance is exactly what pharma has been building toward. Expect the mechanism to outrun the dietary advice.
The honest read is that a population average is being applied to individuals with wildly different training loads. That’s a design flaw, not a scandal — but it means the answer to “how much protein should I eat” starts with a question about your week, not your weight.
Reporting on published research, not medical advice. Protein needs vary with pregnancy, kidney function, age and medication; take individual decisions to a clinician who knows your history.